Authors : Youness Sebbahi; Abdelhakim Hinda; Chaouki El Bied; Yasmina Tadlaoui; Jaouad Kouach

Volume/Issue : Volume 10 - 2025, Issue 3 - March

Google Scholar : https://tinyurl.com/k4jk5swy

Scribd : https://tinyurl.com/28nx7r8x

DOI : https://doi.org/10.38124/ijisrt/25mar817

Google Scholar

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 15 to 20 days to display the article.

Abstract : Introduction Artificial labor induction is increasingly common globally and in Morocco. However, disparities persist in the methods used and the training of professionals. Prostaglandins, particularly misoprostol and dinoprostone, are widely utilized, but their use raises concerns regarding effectiveness, safety, and pharmacovigilance.  Objectives: This study aims to evaluate the practices of healthcare professionals in the Rabat region, Morocco, regarding artificial labor induction, identify preferences for the agents used, and analyze their knowledge. It also seeks to optimize the use of artificial induction agents while ensuring effective and appropriate hospital management.  Materials and Methods: This is a prospective, descriptive, and analytical study conducted between November 2024 and January 2025 among gynecologists in the Rabat region. An exhaustive sampling included practitioners from both public and private sectors, as well as specialists in training. Data were collected using a validated questionnaire and analyzed with Microsoft Excel 2019.  Results: The study revealed that 92% of practitioners regularly use prostaglandins for labor induction. Among them, 56% prefer dinoprostone due to its safety profile, while misoprostol is favored for its effectiveness and cost. However, 72% of respondents had no specific training on these agents, and 76% do not systematically report adverse effects. These gaps contribute to heterogeneous practices and insufficient pharmacovigilance. A notable paradox was identified: although misoprostol is considered more effective, its use is associated with a higher risk of adverse effects, such as uterine hypertonia and fetal distress.  Conclusion: This study confirms the importance of adequate and continuous training for healthcare professionals on the use of artificial labor induction agents. The implementation of harmonized national protocols could reduce regional disparities, improve clinical practices, and enhance pharmacovigilance. Integrating these strategies into training programs and obstetric care pathways is crucial to optimizing maternal-fetal outcomes while ensuring maximum safety.

Keywords : Artificial Labor Induction, Prostaglandins, Misoprostol, Dinoprostone, Labor Induction Methods.

References :

1. National Perinatal Survey 2021 [Internet]. [cited 2025 Jan 25]. Available from: https://www.santepubliquefrance.fr/etudes-et-enquetes/enquete-nationale-perinatale-2021
2. National Perinatal Survey 2016. Births and establishments, situation and evolution since 2010 | Directorate for Research, Studies, Evaluation, and Statistics [Internet]. [cited 2025 Jan 25]. Available from: https://drees.solidarites-sante.gouv.fr/publications/rapports/enquete-nationale-perinatale-2016-les-naissances-et-les-etablissements
3. Osterman MJK, Hamilton BE, Martin JA, Driscoll AK, Valenzuela CP. Births: final data for 2020. [cited 2025 Jan 25]; Available from: https://stacks.cdc.gov/view/cdc/112078
4. Public Health Agency of Canada. Perinatal health indicators in Canada 2017 [Internet]. 2017 [cited 2025 Jan 25]. Available from: https://www.canada.ca/fr/sante-publique/services/prevention-blessures/division-surveillance-sante-epidemiologie/sante-maternelle-infantile/indicateurs-sante-perinatale-2017.html
5. Haute Autorité de Santé - Professional best practice recommendations for the social and medico-social sector [Internet]. [cited 2025 Jan 25]. Available from: https://www.has-sante.fr/jcms/p_3229902/fr/recommandations-de-bonnes-pratiques-professionnelles-pour-le-secteur-social-et-medico-social
6. Thompson R, Miller A, Patel S, et al. Comparison of prostaglandins in labor induction: A retrospective study. J Obstet Gynecol. 2019.
7. Silfeler DB, Tandogan B, Ayvaci H, Silfeler I, Yenidede I, Dayicioglu V. A comparison of misoprostol, controlled-release dinoprostone vaginal insert and oxytocin for cervical ripening. Arch Gynecol Obstet. Dec 2011;284(6):1331‑7.
8. Denguezli W, Trimech A, Haddad A, Hajjaji A, Saidani Z, Faleh R, et al. Efficacy and safety of six-hourly vaginal misoprostol versus intracervical dinoprostone: a randomized controlled trial. Arch Gynecol Obstet. Aug 1, 2007;276(2):119‑24.
9. Sire F, Ponthier L, Eyraud JL, Catalan C, Aubard Y, Coste Mazeau P. Comparative study of dinoprostone and misoprostol for induction of labor in patients with premature rupture of membranes after 35 weeks. Sci Rep. Sep 2, 2022;12(1):14996.